Group of LncRNA biological markers for diagnosing human lung squamous carcinoma
A biomarker, lung squamous cell carcinoma technology, applied in the biological field, can solve problems such as the lack of a good evaluation of the potential of lncRNA
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0042] 1 Clinical sample collection:
[0043] 63 pairs of fresh frozen tissue specimens of early lung squamous cell carcinoma and their paired normal lung tissues were collected from Zhongshan Hospital Affiliated to Fudan University and the Institute of Cells, Chinese Academy of Sciences during 2013-2014. All patients gave informed consent to participate in the scientific research.
[0044] 2LncRNA quantitative PCR experiment:
[0045] 2.1 RNA extraction and quantitative PCR
[0046] Total RNA was extracted from frozen tissues using Trizol, and RNA was quantified using a microvolume spectrophotometer.
[0047] 2.2 Internal reference genes and primers
[0048] The internal reference gene selects β-actin, β-actin and a set of primer sequences of LncRNA biomarkers provided by the present invention as shown in Table 1:
[0049] Table 1 Primer sequences used in quantitative PCR
[0050]
[0051]
[0052] 2.3 Reverse transcription reaction
[0053] Use the SuperScriptⅢFi...
PUM
Property | Measurement | Unit |
---|---|---|
Sensitivity | aaaaa | aaaaa |
Sensitivity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com